Skip To Content
Search
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Type
All
AllStoriesVideoAudioGraphicsBusinessweek
Sort
By Newest
By NewestBy RelevanceBy Oldest
Time
Any Time
Any TimeLast 24 HoursPast WeekPast Month

Showing results for "TTI"

relates to EJMR Economics Forum Posts Unmask Field’s Racism and Sexism
businessweek
EJMR Economics Forum Posts Unmask Field’s Racism and Sexism
By Christopher Beam and Catarina Saraiva
EJMR, an online discussion board for economists, is rife with misogyny and racism, revealing a very dark side of the profession.
March 15, 2024
relates to Jim Egan on the Impact of an 8% Mortgage Rate
markets
Jim Egan on the Impact of an 8% Mortgage Rate
By Tracy Alloway, Joe Weisenthal, and Aashna Shah
Rates continue to rise
October 19, 2023
relates to West Coast Port Terminal to Close Monday as Disruptions Persist
business
West Coast Port Terminal to Close Monday as Disruptions Persist
By Alicia Diaz and Laura Curtis
At least one terminal at the Port of Long Beach will be shut on Monday, seeming to extend disruptions that have hit several key US West Coast port terminals as dockworkers and their employers hold ongoing labor contract negotiations.
June 4, 2023
relates to Social Media Buzz: March for Our Lives, Justin Bieber, Inflation
politics
Social Media Buzz: March for Our Lives, Justin Bieber, Inflation
By Alicia Diaz
What’s buzzing on social media this morning:
June 11, 2022
relates to Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion
business
Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion
By John Lauerman
Pfizer Inc., maker of a top-selling Covid vaccine, will buy all the shares of Trillium Therapeutics Inc. it doesn’t own, gaining the immune cancer drugmaker for an equity value of $2.26 billion.
August 23, 2021
relates to Taiwan Under Pressure to Work With China to Secure Vaccines
politics
Taiwan Under Pressure to Work With China to Secure Vaccines
By Iain Marlow, Dong Lyu, and Cindy Wang
Taiwan’s government faces mounting pressure to work with China to obtain Covid-19 vaccines, a politically unpalatable option for officials in Taipei struggling with an outbreak that risks disrupting tech supply chains.
May 27, 2021
relates to Traders Sift Through Hematology Meeting’s Winners and Losers
markets
Traders Sift Through Hematology Meeting’s Winners and Losers
By Bailey Lipschultz
Biotechnology stocks rallied to a record Monday in reaction to a deluge of data from companies studying blood disease treatments presented at the start of the American Society of Hematology (ASH) annual meeting, one of the year’s largest medical conferences.
December 7, 2020
relates to Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting
markets
Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting
By Bailey Lipschultz
High-flying drug developers that have surged in the face of the ongoing coronavirus pandemic will be in focus starting this weekend at the year’s last big medical meeting, putting surging stocks under the microscope for investors who have cheered massive gains.
December 4, 2020
relates to Tetra’s (TTI) Calcium Chloride Is Fueling a Cocaine War in South America
businessweek
Tetra’s (TTI) Calcium Chloride Is Fueling a Cocaine War in South America
By Michael Smith and Cam Simpson
Tetra Technologies wanted to boost sales of calcium chloride, a compound with lots of commercial applications. Now Colombian drug lords are asking for it by name.
October 26, 2020
relates to Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge
markets
Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge
By Bailey Lipschultz
When Jan Skvarka joined biotechnology firm Trillium Therapeutics Inc. as chief executive officer, he made a big bet to reshape the company and went all-in on a cancer treatment platform. Now, he’s reaping the rewards.
September 30, 2020